Oral Tirzepatide in 2026: Who Actually Offers It and What It Costs
There is no FDA-approved oral tirzepatide. Not "not yet widely available" — as of July 2026, zero human clinical trials of an oral tirzepatide product have been published, and Eli Lilly's own medical affairs team has stated plainly that tirzepatide isn't sold in pill form. That hasn't stopped a handful of compounding pharmacies from selling sublingual and dissolvable-tablet versions anyway. Here's the actual science, followed by who sells it and what it costs.
Why Oral Tirzepatide Is a Much Harder Problem Than Oral Semaglutide
Semaglutide is already a large molecule for an oral drug, and even it needs SNAC — a purpose-built absorption enhancer — to reach a usable (if still low, 0.4–1%) bioavailability in Rybelsus and the Wegovy pill. Tirzepatide is a bigger problem on every axis:
- Size. At roughly 4,813 daltons, tirzepatide is about 10 times heavier than the rough 500-dalton ceiling for reliable passive absorption through the gut wall.
- Structure. It's a 39-amino-acid synthetic peptide engineered for a multi-day half-life in the bloodstream — the same properties that make it effective as an injectable make it fragile in the stomach, where acid and digestive enzymes are built specifically to break peptide bonds apart.
- No validated enhancer. SNAC was engineered and clinically validated specifically for semaglutide's chemistry. No published, validated absorption enhancer exists for tirzepatide.
The strongest evidence for how seriously the industry takes this barrier: Lilly didn't try to build an oral tirzepatide. It developed orforglipron (Foundayo) instead — a completely different, much smaller molecule that only targets the GLP-1 receptor rather than tirzepatide's dual GIP/GLP-1 mechanism. That pivot is itself a signal about how solvable the oral-tirzepatide problem currently is.
So What Are Compounding Pharmacies Actually Selling?
Sublingual drops, dissolvable tablets, and orally disintegrating tablets (ODTs) that contain compounded tirzepatide, on the theory that the tissue under the tongue can absorb the drug without it passing through the stomach at all. This bypasses the gastric-enzyme problem in theory, but the same size and structure issues that limit stomach absorption also limit sublingual absorption for a molecule this large. No published human clinical trial has established a meaningful bioavailability number for any compounded oral or sublingual tirzepatide product.
That's a genuinely different risk profile than the compounded oral semaglutide market, where the science is still unproven but at least the target molecule is closer in size to something SNAC was built to handle. Read our oral semaglutide price comparison if that's what you're actually looking for — it may be the more defensible route if a needle-free option matters to you.
Who Currently Offers Compounded Oral Tirzepatide
If you've weighed the science above and still want to try a compounded oral tirzepatide product, here's who we track:
| Provider | Format | Price |
|---|---|---|
| MadeMed | Sublingual | $229/mo |
| Sprout Health | Dissolvable tablet | $249–$299/mo |
| SkinnyRx | Sublingual / buccal tablet | $299/mo |
| Wellorithm † | Sublingual (unconfirmed) | $249/mo (reported) |
| Synergy Rx | Orally disintegrating tablet | $399/mo |
† Wellorithm's oral/sublingual format is still being confirmed directly with the provider — treat this listing as reported, not verified.
Synergy Rx: An Honorable Mention
Synergy Rx also lists an oral tirzepatide product at $399/mo, the highest price on this list. We've deprioritized it in our own recommendations due to a lack of dedicated landing-page infrastructure, but it remains a legitimate option if the providers above don't fit your situation.
The Bottom Line on Oral Tirzepatide
If you specifically need tirzepatide rather than semaglutide — because you've responded better to it, or your provider has recommended it — the honest answer in 2026 is that the injectable pen remains the only version with real clinical evidence behind it. The compounded oral options above exist and are legal to sell under narrow patient-specific compounding rules, but you're buying into a genuinely unproven absorption technology, not a shortcut version of the same drug. If oral administration itself is the priority and you're open to a different active ingredient, Foundayo (orforglipron) is the FDA-approved alternative worth discussing with a provider — see our Foundayo vs. Wegovy pill vs. compounded comparison.